Quay Pharma is a UK-based provider of innovative, formulation research and development services for the global biopharmaceutical sector.

SGS will publish its 2021 Integrated Reports in mid-February 2022.

This acquisition enhances our Sustainability Solutions, supporting our customers on their sustainability journey.

This represents a key milestone in the integration of our financial and sustainability strategies and further positions the Group as a sustainability leader.

IDEA is a leading provider of clinical, microbiological and in-vitro testing in France.

We’ve delivered a strong financial performance in H1.

Metair Lab provides air sampling and asbestos testing services in France.

During our 2021 Investor Days, we’re sharing the next phase of our strategic evolution, further aligning SGS to the key TIC ‘megatrends’ and to customer demand.

We’re raising the bar for industry standards and supporting our culture of sustainability.

Brightsight is the world’s leading cybersecurity evaluation laboratory network for chip-based security products.